Overview Fundamentals API Earnings EOD API Sample Code Pricing

Eiger BioPharmaceuticals Inc (EIGRQ PINK) stock market data APIs

$11.5 -0.21(-1.8%) as of July 12, 2024
Price chart is built with Anychart

Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development of therapies for hepatitis delta virus (HDV) and other serious diseases. The company offers Zokinvy for the treatment of Hutchinson-Gilford progeria syndrome and Processing-Deficient Progeroid Laminopathies. Its product candidates include Lonafarnib, an orally available, farnesylation inhibitor, which has completed Phase 3 clinical trials for HDV infection; Peginterferon Lambda (lambda), which is in clinical development for HDV; lambda, that is in phase II and III investigator studies of mild and moderate COVID-19; and Avexitide, which is in Phase II for the treatment of congenital hyperinsulinism and post-bariatric hypoglycemia. The company is headquartered in Palo Alto, California. On April 1, 2024, Eiger BioPharmaceuticals, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Northern District of Texas.

Eiger BioPharmaceuticals Inc Financial Data Overview

11.71
11.5
-
11.71
11.49
1.1-28.5
0
0
0
-49.39
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'EIGRQ',
Type: 'Common Stock',
Name: 'Eiger BioPharmaceuticals Inc',
Exchange: 'PINK',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG0026ZCTG7',
ISIN: NULL,
CUSIP: NULL,
CIK: '1305253',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2014-01-30',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

Eiger BioPharmaceuticals Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA 0
  • Earnings Per Share
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Eiger BioPharmaceuticals Inc Earnings via APIs

  • Latest Release 2024-04-08
  • EPS/Forecast -7.5

Get Eiger BioPharmaceuticals Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Eiger BioPharmaceuticals Inc latest news via APIs

Do you have any questions?
support@eodhistoricaldata.com